Abortion Pill Makers Ask Supreme Court to Allow Mail-Order Abortions

The makers of the abortion pill mifepristone asked the Supreme Court on Saturday to overturn a federal appeals court ruling that temporarily blocks the mailing of the drug nationwide.

The ruling has the potential to save tens of thousands of babies from abortions and thousands of women from medical problems or even death.

But abortion drug maker Danco Laboratories filed an emergency application seeking to lift the U.S. Court of Appeals for the 5th Circuit’s order, which on Friday reinstated the requirement that mifepristone be dispensed in person. The requirement protects women’s health and could save thousands of babies.

Click Like if you are pro-life to like the LifeNews Facebook page!

GenBioPro, another manufacturer, filed a similar request.

The 5th Circuit sided with Louisiana, which sued the Biden administration over its policy allowing telemedicine prescriptions and mail delivery of the abortion pill. The state argued the changes undermined its abortion ban and forced it to spend Medicaid funds on emergency care for women harmed by the drug. The ruling restores the in-person dispensing safeguard the FDA had lifted during the COVID-19 pandemic and made permanent in 2023 under Joe Biden.

Louisiana Attorney General Liz Murrill praised the appeals court decision.

“The Biden abortion cartel facilitated the deaths of thousands of Louisiana babies (and millions in other states) through illegal mail-order abortion pills,” Murrill said. “Today, that nightmare is over, thanks to the hard work of my office and our friends at Alliance Defending Freedom. I look forward to continuing to defend women and babies as this case continues.”

Pro-life groups called the ruling an important victory for women’s safety and the protection of unborn children.

National Right to Life President Carol Tobias said it was “an important step toward restoring common-sense medical safeguards that were recklessly discarded by the Biden administration in the rush to expand abortion pill access.”

She noted that mail-order abortion drugs bypass basic protections such as physical exams, accurate pregnancy dating and screening for ectopic pregnancy.

The Supreme Court has not yet acted on the manufacturers’ requests.

Mifepristone, approved by the FDA in 2000, accounts for nearly two-thirds of abortion deaths in the United States.

Pro-life advocates have warned that the mail-order system endangers women by removing medical oversight for complications while enabling the destruction of unborn children in states that ban abortion. The 5th Circuit panel said the FDA’s changes undermined Louisiana’s laws protecting unborn human life.